Tenho deficiência de IgA — Por que o médico não me aplica logo Imunoglobulina Subcutânea?
In the realm of allergic and immune-mediated diseases, the topic Tenho deficiência de IgA It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Tenho deficiência de IgA — Por que o médico não me aplica logo Imunoglobulina Subcutânea?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.
Complementary Audiovisual Content: Click here to watch the full explanatory video on the official Brasil Sem Alergia YouTube channel..
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Deficiência Seletiva de IgA e o Uso de Imunoglobulina Subcutânea
Uma dúvida frequente entre pacientes que conviven com a deficiência seletiva de IgA (imunoglobulina A) diz respeito à possibilidade de tratamento com a reposição de imunoglobulina subcutânea. Como essa medicação é amplamente utilizada em outros quadros de imunodeficiências primárias, é natural que surja o questionamento sobre o motivo de o médico especialista não indicá-la rotineiramente para este diagnóstico específico.
Do ponto de vista científico e imunológico, a imunoglobulina disponível para reposição terapêutica é composta predominantemente por anticorpos da classe IgG. A IgA é a principal imunoglobulina encontrada nas secreções e mucosas do organismo (como nos sistemas respiratório e gastrointestinal), desempenhando um papel crucial na defesa local dessas regiões. Estudos clínicos demonstraram que a administração exógena de imunoglobulina não consegue reproduzir adequadamente a proteção conferida pela IgA secretora nas mucosas, não apresentando a eficácia esperada para este grupo de pacientes.
Além da questão relacionada à eficácia terapêutica, a segurança do procedimento é um fator limitante determinante. A literatura médica aponta que pacientes com deficiência seletiva de IgA que recebem infusões de imunoglobulina apresentam um risco significativamente maior de desenvolver reações alérgicas graves, incluindo o choque anafilático. Isso ocorre muitas vezes devido à formação de anticorpos contra a própria IgA presente no hemoderivado.
Diante da impossibilidade de realizar a reposição com imunoglobulina, o manejo clínico da deficiência de IgA é focado na prevenção rigorosa de infecções e no suporte imunológico adequado:
- Manutenção rigorosa e completa do cartão de vacinação disponibilizado pelo Sistema Único de Saúde (SUS) em dia.
- Busca por vacinas especiais ou não contempladas na rede pública, quando recomendadas pelo médico assistente, utilizando-se dos meios legais e da Defensoria Pública para garantir o acesso a esses imunizantes pelo Estado, mediante laudo médico detalhado.
Este conteúdo possui caráter exclusivamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e o acompanhamento individualizado com um médico especialista em Alergia e Imunologia.
Developments in Evidence-Based Medicine: Vaccine Immunology and Allergen-Specific Immunotherapy
In Evidence-Based Medicine (WHO, EAACI and ASBAI), two complementary strategies for modulating the immune system are distinguished: (1) the preventive anti-infectious immunizing vaccines, which stimulate humoral (neutralizing IgG/IgA antibodies) and cellular (memory T lymphocytes) adaptive immunity against viral and bacterial pathogens; and (2) a Allergen-specific immunotherapy (allergy vaccines), the only treatment that modifies the natural history of IgE-mediated allergic diseases. The controlled and progressive administration of standardized allergenic extracts promotes an immunological shift from the Th2 to the Th1 profile, inducing the expansion of regulatory T lymphocytes (CD4)+CD25+FOXP3+) producers of IL-10 and TGF-β and stimulates the synthesis of IgG4 subclass blocking antibodies, thus sustainably reducing clinical hyper-reactivity and the need for symptomatic drugs.
💎 Diamond Plan — Doenças imunológicas complexas exigem acompanhamento especializado e contínuo. Fale com um especialista em Alergia e Imunologia por teleconsulta, de qualquer cidade do Brasil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Safe Immunization, Immune Response, and Protection of the Allergic Patient
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.
Integration between Vaccination Schedule, Allergy Tests and Baseline Monitoring
Individualized assessment by an allergist and immunologist correlates laboratory tests of cellular and humoral immunity with the patient's actual clinical history. Combining the allergy test well indicated for preventive monitoring — including allergy vaccine In cases of atopic dermatitis, and with immunostimulant vaccines when applicable, broad, safe protection based on scientific evidence is guaranteed.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan foi desenhado para pacientes de todo o Brasil que enfrentam o alto custo das vacinas alérgicas e as dificuldades de deslocamento, oferecendo acompanhamento especializado por telemedicina e acesso facilitado ao tratamento imunoterápico. Doenças imunológicas complexas exigem acompanhamento especializado e contínuo.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Tenho deficiência de IgA It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




